Market Access Views & Analysis

Views & Analysis

Latin America: How pharma can navigate a complex market

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened t

Articles

A history of Pfizer

In the next part of his series on the history of the pharmaceutical industry, Robin Walsh looks at the biggest company of them all – Pfizer. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart...

Views & Analysis

The calm after the storm: How COVID-19 is making pharma more...

COVID-19 is proving to be the perfect storm in terms of the supply of pharmaceutical products.

Market Access

Helping to support momentum on antimicrobial innovation

COVID-19: Helping to support momentum on antimicrobial innov...

To mark World Antimicrobial Awareness Wee

Views & Analysis

Vertex Pharma’s vision for reimbursement innovation

As regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s novel cystic fibrosis drug Kaftrio.

R&D

Enabling innovation by connecting an ecosystem of partners

COVID-19 has been a shock to the system for every industry, not least pharma, but the sector is already looking at new ways to build resilience for the future.

Latin America: How pharma can navigate a complex market

A history of Pfizer

The calm after the storm: How COVID-19 is making pharma more...

COVID-19: Helping to support momentum on antimicrobial innov...

Vertex Pharma’s vision for reimbursement innovation

Enabling innovation by connecting an ecosystem of partners

BioMarin ends year with $4.8bn play for Amicus

How to meet your physicians where they are online

Views & Analysis

Editor's Picks